Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenyang Liu

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Cancer Immunology, Immunotherapy : CII|November 18, 2025
Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching studyQi Liu, Junqiang Chen, Yuanji Xu, et al.
Frontiers in Oncology|December 30, 2021
A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk AnalysisShuang Sun, Yu Men, Jingjing Kang, et al.
BMC Cancer|February 27, 2022
Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysisNing Li, Xiaoyong Xiang, Dongbin Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 12, 2025
A multidimensional deep ensemble learning model predicts pathological response and outcomes in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy from pretreatment CT imaging: A multicenter studyYunsong Liu, Yang Su, Jun Peng, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapyLin-Rui Gao, Chen Li, Weiming Han, et al.
Frontiers in Oncology|November 28, 2022
Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinomaWeiming Han, Wei Deng, Qifeng Wang, et al.
Thoracic Cancer|November 28, 2020
Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical marginsMeng Yuan, Yu Men, Jingjing Kang, et al.
Frontiers in Oncology|September 28, 2020
S-1-Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II TrialXin Wang, Xiaolin Ge, Xiaomin Wang, et al.
JAMA Network Open|May 17, 2023
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical TrialXin Wang, Weiming Han, Wencheng Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2025
Long-term outcomes of S-1-based chemoradiotherapy in inoperable elderly patients with esophageal carcinoma: A multicenter, randomized, phase III clinical trialJunqiang Chen, Xiao Chang, Wenyang Liu, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cancer Immunology, Immunotherapy : CII|November 18, 2025
Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching studyQi Liu, Junqiang Chen, Yuanji Xu, et al.
Frontiers in Oncology|December 30, 2021
A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk AnalysisShuang Sun, Yu Men, Jingjing Kang, et al.
BMC Cancer|February 27, 2022
Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysisNing Li, Xiaoyong Xiang, Dongbin Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 12, 2025
A multidimensional deep ensemble learning model predicts pathological response and outcomes in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy from pretreatment CT imaging: A multicenter studyYunsong Liu, Yang Su, Jun Peng, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapyLin-Rui Gao, Chen Li, Weiming Han, et al.
Frontiers in Oncology|November 28, 2022
Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinomaWeiming Han, Wei Deng, Qifeng Wang, et al.
Thoracic Cancer|November 28, 2020
Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical marginsMeng Yuan, Yu Men, Jingjing Kang, et al.
Frontiers in Oncology|September 28, 2020
S-1-Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II TrialXin Wang, Xiaolin Ge, Xiaomin Wang, et al.
JAMA Network Open|May 17, 2023
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical TrialXin Wang, Weiming Han, Wencheng Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2025
Long-term outcomes of S-1-based chemoradiotherapy in inoperable elderly patients with esophageal carcinoma: A multicenter, randomized, phase III clinical trialJunqiang Chen, Xiao Chang, Wenyang Liu, et al.
Pageof 8